These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 480165)

  • 21. Diuretic agents related to indapamide. IV--Synthesis and pharmacological activity of N-(4-chloro-3-sulfamoylbenzamido)-methyl-phenyl-pyrrolidines and N1-(4-chloro-3-sulfamoylbenzoyl)-N2-aryl- or aralkyl-alkyl-hydrazines.
    Cignarella G; Barlocco D; Landriani L; Pinna GA; Andriuoli G; Donà G
    Farmaco; 1991 Apr; 46(4):527-38. PubMed ID: 1930551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
    Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
    Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular effects of indapamide on frog hearts and open-chest cats.
    Hemwall EL; Dipalma JR
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):225-37. PubMed ID: 6971631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence-based diuretics: focus on chlorthalidone and indapamide.
    DiNicolantonio JJ; Bhutani J; Lavie CJ; O'Keefe JH
    Future Cardiol; 2015 Mar; 11(2):203-17. PubMed ID: 25760879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy and quality of life with indapamide alone or in combination with beta blockers or angiotensin-converting enzyme inhibitors.
    Athanassiadis DI; Dimopoulos CG; Tsakiris AK; Cokkinos DF; Tourkantonis AA; Toutouzas PK; Boutin B; Guez D
    Am J Cardiol; 1990 May; 65(17):62H-66H. PubMed ID: 2184654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of indapamide to serum proteins and erythrocytes.
    Urien S; Riant P; Renouard A; Coulomb B; Rocher I; Tillement JP
    Biochem Pharmacol; 1988 Aug; 37(15):2963-6. PubMed ID: 3395370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid-state compatibility screening of excipients suitable for development of indapamide sustained release solid-dosage formulation.
    Antovska P; Petruševski G; Makreski P
    Pharm Dev Technol; 2013; 18(2):481-9. PubMed ID: 22998073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indapamide--a substitute diuretic for hypertensives with hyperglycemia and/or dyslipidemia].
    Sharabi Y; Grossman E; Nussinovitch N; Katz A; Rachima-Moaz C; Rosenthal T
    Harefuah; 1996 Oct; 131(7-8):233-6, 295. PubMed ID: 8940516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indapamide-induced inhibition of calcium movement in smooth muscles.
    Mironneau J
    Am J Med; 1988 Jan; 84(1B):10-4. PubMed ID: 2449075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indapamide: a review.
    Reyes AJ; Leary WP
    S Afr Med J; 1983 Nov; Suppl():1-6. PubMed ID: 6356402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.
    Yamada H; Mishiro Y; Kusunose K; Sata M
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):145-50. PubMed ID: 20200326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide.
    Plante GE; Dessurault DL
    Am J Med; 1988 Jan; 84(1B):98-103. PubMed ID: 3341391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
    Bing RF; Russell GI; Swales JD; Thurston H
    Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [All diuretics used in the treatment of hypertension are not the same].
    Asil S; Atalar E
    Turk Kardiyol Dern Ars; 2017 Jan; 45(1):94-101. PubMed ID: 28106027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of indapamide determined from powered diffraction data.
    Smrkolj M; Meden A
    Pharmazie; 2006 Dec; 61(12):999-1004. PubMed ID: 17283656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compared effects of indapamide, hydrochlorothiazide and chlorthalidone on electrical and mechanical activities in vascular smooth muscle.
    Mironneau J; Savineau JP; Mironneau C
    Eur J Pharmacol; 1981 Oct; 75(2-3):109-13. PubMed ID: 7318900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs.
    Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.
    Chaffman M; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Sep; 28(3):189-235. PubMed ID: 6489195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorometric assay for urinary indapamide.
    Grebow PE; Treitman JA; Yeung AK
    J Pharm Sci; 1978 Aug; 67(8):1117-20. PubMed ID: 671249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological degradation of bile acids. Metabolites formed from 3-(3a alpha-hexahydro-7a beta-methyl-1,5-dioxoindan-4 alpha-yl) propionic acid by Streptomyces rubescens.
    Hashimoto S; Hayakawa S
    Biochem J; 1977 Jun; 164(3):715-26. PubMed ID: 883963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.